Apimeds Pharmaceuticals US, Inc. (APUS) institutional holders · $2.4M cap
No 13F filings for quarters ended 2026-06-30 or later list Apimeds Pharmaceuticals US, Inc. yet.
No current-quarter 13F holders on file for APUS yet.
These 13F holders as JSON? API free 100/dayNot investment advice. Figures as filed or reported, not a live feed.